Haemoglobin, blood volume, cardiac function, and aerobic power
- PMID: 9916181
- DOI: 10.1139/h99-006
Haemoglobin, blood volume, cardiac function, and aerobic power
Abstract
Alterations in [Hb], which are mediated through changes in arterial oxygen content, and alterations in BV, which are mediated through changes in cardiac output (Q), have a significant effect on both VO2max and aerobic performance. If BV is held constant, a decrease in [Hb] (anaemia) causes a decrease in VO2max and aerobic performance, while an increase in [Hb] (blood doping) causes an increase in VO2max and aerobic performance. If [Hb] is held constant, an increase in BV can cause and increase in both VO2max and aerobic performance, while a decrease in BV can cause a decrease in VO2max and aerobic performance. In addition, an increase in BV can compensate for moderate reductions in [Hb] through increase in Q, allowing VO2max to remain unchanged or even increase. Also, a large portion of the difference in the enhanced cardiovascular function of endurance athletes is due to their high BV and the resultant enhancement of diastolic function. Hence, optimizing both [Hb] and BV is a very important consideration for endurance performance.
Similar articles
-
Drugs for increasing oxygen and their potential use in doping: a review.Sports Med. 2003;33(3):187-212. doi: 10.2165/00007256-200333030-00003. Sports Med. 2003. PMID: 12656640 Review.
-
Blood volume, aerobic power, and endurance performance: potential ergogenic effect of volume loading.Clin J Sport Med. 2000 Jan;10(1):59-66. doi: 10.1097/00042752-200001000-00011. Clin J Sport Med. 2000. PMID: 10695852
-
Induced hypervolemia, cardiac function, VO2max, and performance of elite cyclists.Med Sci Sports Exerc. 1999 Jun;31(6):800-8. doi: 10.1097/00005768-199906000-00007. Med Sci Sports Exerc. 1999. PMID: 10378906 Clinical Trial.
-
Intermittent hypoxia as a means to improve aerobic capacity in type 2 diabetes.Med Hypotheses. 2017 Mar;100:59-63. doi: 10.1016/j.mehy.2017.01.010. Epub 2017 Jan 23. Med Hypotheses. 2017. PMID: 28236850
-
Blood boosting and sport.Baillieres Best Pract Res Clin Endocrinol Metab. 2000 Mar;14(1):89-98. doi: 10.1053/beem.2000.0056. Baillieres Best Pract Res Clin Endocrinol Metab. 2000. PMID: 10932813 Review.
Cited by
-
Haemoglobin concentration and mass as determinants of exercise performance and of surgical outcome.Extrem Physiol Med. 2013 Nov 26;2(1):33. doi: 10.1186/2046-7648-2-33. Extrem Physiol Med. 2013. PMID: 24280034 Free PMC article.
-
Drugs for increasing oxygen and their potential use in doping: a review.Sports Med. 2003;33(3):187-212. doi: 10.2165/00007256-200333030-00003. Sports Med. 2003. PMID: 12656640 Review.
-
Cardiac parasympathetic reactivation following exercise: implications for training prescription.Sports Med. 2013 Dec;43(12):1259-77. doi: 10.1007/s40279-013-0083-4. Sports Med. 2013. PMID: 23912805 Review.
-
Faster oxygen uptake kinetics at the onset of submaximal cycling exercise following 4 weeks recombinant human erythropoietin (r-HuEPO) treatment.Pflugers Arch. 2003 Nov;447(2):231-8. doi: 10.1007/s00424-003-1174-0. Epub 2003 Sep 30. Pflugers Arch. 2003. PMID: 14551773 Clinical Trial.
-
The treatment of chronic anemia in heart failure: a global approach.Clin Res Cardiol. 2024 Aug;113(8):1117-1136. doi: 10.1007/s00392-023-02275-4. Epub 2023 Sep 3. Clin Res Cardiol. 2024. PMID: 37660308 Review.